- Report
- January 2022
- 110 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 90 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 115 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 112 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 110 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 120 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 122 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 117 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 105 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- July 2021
- 120 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- July 2021
- 116 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- August 2020
- 112 Pages
Global
From €4198EUR$4,250USD£3,492GBP
- Report
- June 2020
- 114 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- October 2023
- 54 Pages
Global
From €4889EUR$4,950USD£4,068GBP
- Report
- August 2023
- 102 Pages
Global
From €3284EUR$3,325USD£2,732GBP
€4691EUR$4,750USD£3,903GBP
- Report
- June 2024
- 200 Pages
From €5496EUR$5,565USD£4,573GBP
€7852EUR$7,950USD£6,533GBP
- Report
- April 2024
- 30 Pages
China
From €1556EUR$1,575USD£1,294GBP
€2222EUR$2,250USD£1,849GBP
- Report
- November 2023
- 30 Pages
Global
From €2247EUR$2,275USD£1,869GBP
€3210EUR$3,250USD£2,671GBP
- Report
- November 2023
- 30 Pages
Global
From €2247EUR$2,275USD£1,869GBP
€3210EUR$3,250USD£2,671GBP
- Report
- November 2023
- 30 Pages
Global
From €2247EUR$2,275USD£1,869GBP
€3210EUR$3,250USD£2,671GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more